| Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial RECOVERY Collaborative Group Lancet (London, England) 397 (10285), 1637, 2021 | 2312* | 2021 |
| Causes of blindness and vision impairment in 2020 and trends over 30 years, and prevalence of avoidable blindness in relation to VISION 2020: the Right to Sight: an analysis … JD Steinmetz, RRA Bourne, PS Briant, SR Flaxman, HRB Taylor, ... The Lancet Global Health 9 (2), e144-e160, 2021 | 1853 | 2021 |
| Cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life years for 29 cancer groups from 2010 to 2019: a systematic analysis … JM Kocarnik, K Compton, FE Dean, W Fu, BL Gaw, JD Harvey, ... JAMA oncology 8 (3), 420-444, 2022 | 1502 | 2022 |
| Global mortality associated with 33 bacterial pathogens in 2019: a systematic analysis for the Global Burden of Disease Study 2019 KS Ikuta, LR Swetschinski, GR Aguilar, F Sharara, T Mestrovic, AP Gray, ... The Lancet 400 (10369), 2221-2248, 2022 | 1271 | 2022 |
| The Berkeley Drosophila Genome Project gene disruption project: Single P-element insertions mutating 25% of vital Drosophila genes AC Spradling, D Stern, A Beaton, EJ Rhem, T Laverty, N Mozden, S Misra, ... Genetics 153 (1), 135-177, 1999 | 996 | 1999 |
| Carcinoma of the gallbladder S Misra, A Chaturvedi, NC Misra, ID Sharma The lancet oncology 4 (3), 167-176, 2003 | 928 | 2003 |
| Hearing loss prevalence and years lived with disability, 1990–2019: findings from the Global Burden of Disease Study 2019 LM Haile, K Kamenov, PS Briant, AU Orji, JD Steinmetz, A Abdoli, ... The Lancet 397 (10278), 996-1009, 2021 | 834 | 2021 |
| Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial O Abani, A Abbas, F Abbas, M Abbas, S Abbasi, H Abbass, A Abbott, ... The Lancet 399 (10325), 665-676, 2022 | 751* | 2022 |
| The global burden of cancer attributable to risk factors, 2010–19: a systematic analysis for the Global Burden of Disease Study 2019 KB Tran, JJ Lang, K Compton, R Xu, AR Acheson, HJ Henrikson, ... The Lancet 400 (10352), 563-591, 2022 | 674 | 2022 |
| Spatial, temporal, and demographic patterns in prevalence of smoking tobacco use and attributable disease burden in 204 countries and territories, 1990–2019: a systematic … MB Reitsma, PJ Kendrick, E Ababneh, C Abbafati, M Abbasi-Kangevari, ... The Lancet 397 (10292), 2337-2360, 2021 | 643 | 2021 |
| Timing of surgery following SARS‐CoV‐2 infection: an international prospective cohort study D Lobo, JM Devys Anaesthesia 77 (1), 110, 2021 | 589* | 2021 |
| Apollo: a sequence annotation editor SE Lewis, SMJ Searle, N Harris, M Gibson, V Iyer, J Richter, C Wiel, ... Genome biology 3, 1-14, 2002 | 588 | 2002 |
| Global, regional, and national burden of hepatitis B, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 BS Sheena, L Hiebert, H Han, H Ippolito, M Abbasi-Kangevari, ... The lancet Gastroenterology & hepatology 7 (9), 796-829, 2022 | 530 | 2022 |
| Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the … M Naghavi, KL Ong, A Aali, HS Ababneh, YH Abate, C Abbafati, ... The Lancet 403 (10440), 2100-2132, 2024 | 517 | 2024 |
| Global, regional, and national burden of disorders affecting the nervous system, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 JD Steinmetz, KM Seeher, N Schiess, E Nichols, B Cao, C Servili, ... The Lancet Neurology 23 (4), 344-381, 2024 | 484 | 2024 |
| Population-level risks of alcohol consumption by amount, geography, age, sex, and year: a systematic analysis for the Global Burden of Disease Study 2020 D Bryazka, MB Reitsma, MG Griswold, KH Abate, C Abbafati, ... The Lancet 400 (10347), 185-235, 2022 | 398 | 2022 |
| Global, regional, and national burden of colorectal cancer and its risk factors, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 R Sharma, M Abbasi-Kangevari, R Abd-Rabu, H Abidi, E Abu-Gharbieh, ... The Lancet Gastroenterology & Hepatology 7 (7), 627-647, 2022 | 386 | 2022 |
| Clinical characteristics with inflammation profiling of long COVID and association with 1-year recovery following hospitalisation in the UK: a prospective observational study RA Evans, OC Leavy, M Richardson, O Elneima, HJC McAuley, ... The Lancet Respiratory Medicine 10 (8), 761-775, 2022 | 384 | 2022 |
| Penile carcinoma: a challenge for the developing world S Misra, A Chaturvedi, NC Misra The lancet oncology 5 (4), 240-247, 2004 | 333 | 2004 |
| Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950–2021, and the impact of the … AE Schumacher, HH Kyu, A Aali, C Abbafati, J Abbas, ... The Lancet 403 (10440), 1989-2056, 2024 | 319 | 2024 |
